Administration of CORM-2 inhibits diabetic neuropathy but does not reduce dyslipidemia in diabetic mice

The antinociceptive effects of the carbon monoxide-releasing molecule tricarbonyldichlororuthenium (II) dimer (CORM-2) during chronic pain are well documented, but most of its possible side-effects remain poorly understood. In this work, we examine the impact of CORM-2 treatment on the lipoprotein p...

Descripción completa

Detalles Bibliográficos
Autores principales: Méndez-Lara, Karen Alejandra, Santos, David, Farré, Núria, Ruiz-Nogales, Sheila, Leánez, Sergi, Sánchez-Quesada, José Luis, Zapico, Edgar, Lerma, Enrique, Escolà-Gil, Joan Carles, Blanco-Vaca, Francisco, Martín-Campos, Jesús María, Julve, Josep, Pol, Olga
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6171880/
https://www.ncbi.nlm.nih.gov/pubmed/30286142
http://dx.doi.org/10.1371/journal.pone.0204841

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6171880/
https://www.ncbi.nlm.nih.gov/pubmed/30286142
http://dx.doi.org/10.1371/journal.pone.0204841

Ejemplares similares